6BVF
Cryo-EM Structure of Hepatitis B virus T=4 capsid in complex with the fluorescent allosteric modulator HAP-TAMRA
Summary for 6BVF
| Entry DOI | 10.2210/pdb6bvf/pdb |
| EMDB information | 7294 7295 |
| Descriptor | Capsid protein, Heteroaryldihydropyrimidine tetramethylrodamine (2 entities in total) |
| Functional Keywords | capsid, cpam, antiviral, fluorescent, virus like particle |
| Biological source | Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979) |
| Total number of polymer chains | 4 |
| Total formula weight | 69043.27 |
| Authors | Schlicksup, C.,Wang, J.C.,Zlotnick, A. (deposition date: 2017-12-12, release date: 2018-02-07, Last modification date: 2024-05-15) |
| Primary citation | Schlicksup, C.J.,Wang, J.C.,Francis, S.,Venkatakrishnan, B.,Turner, W.W.,VanNieuwenhze, M.,Zlotnick, A. Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids. Elife, 7:-, 2018 Cited by PubMed Abstract: Defining mechanisms of direct-acting antivirals facilitates drug development and our understanding of virus function. Heteroaryldihydropyrimidines (HAPs) inappropriately activate assembly of hepatitis B virus (HBV) core protein (Cp), suppressing formation of virions. We examined a fluorophore-labeled HAP, HAP-TAMRA. HAP-TAMRA induced Cp assembly and also bound pre-assembled capsids. Kinetic and spectroscopic studies imply that HAP-binding sites are usually not available but are bound cooperatively. Using cryo-EM, we observed that HAP-TAMRA asymmetrically deformed capsids, creating a heterogeneous array of sharp angles, flat regions, and outright breaks. To achieve high resolution reconstruction (<4 Å), we introduced a disulfide crosslink that rescued particle symmetry. We deduced that HAP-TAMRA caused quasi-sixfold vertices to become flatter and fivefold more angular. This transition led to asymmetric faceting. That a disordered crosslink could rescue symmetry implies that capsids have tensegrity properties. Capsid distortion and disruption is a new mechanism by which molecules like the HAPs can block HBV infection. PubMed: 29377794DOI: 10.7554/eLife.31473 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (4 Å) |
Structure validation
Download full validation report






